|
|
2025 |
Evaluating Efficacy Outcomes in Pediatric Multiple Sclerosis Patients While Using Avonex or Plegridy via USNPMSC Registry |
Wright M et al. |
J Child Neurol. |
Treatment, Outcomes, Registry |
|
|
2025 |
Real-World Effectiveness of Switching to Oral or Infusion Versus Injectable Disease-Modifying Therapy in Pediatric Multiple Sclerosis |
Abrams AW et al. |
Ann Neurol. |
Treatment, Outcomes |
|
|
2025 |
Cognitive Function in People With Pediatric Multiple Sclerosis Over 2 Years |
O'Neill KA et al. |
Neurology |
Cognition, Outcomes |
|
|
2025 |
Telomere length as a marker of biological age in paediatric multiple sclerosis |
Jacques et al. |
Mult Scler. |
Aging, Biomarkers |
|
|
2025 |
Epigenetic age and telomere length correlations in pediatric-onset multiple sclerosis |
Yang J et al. |
J Neurol Neurosurg Psychiatry |
Aging, Epigenetics, Biomarkers |
|
|
2025 |
Limited early IVIG for the treatment of pediatric myelin oligodendrocyte glycoprotein antibody-associated disease |
MacRae R et al. |
Mult Scler Relat Disord. |
Treatment, MOG |
|
|
2025 |
Allele-specific vitamin D receptor binding is associated with pediatric-onset multiple sclerosis |
Yilmaz D et al. |
Mult Scler. |
Genetics, Vitamin D |
|
|
2025 |
Study of the Association Between Menarche and Disease Course in Pediatric Multiple Sclerosis |
Krysko K et al. |
Neurology |
Outcomes, Risk Factors |
|
|
2024 |
Epigenetic Aging in Pediatric-Onset Multiple Sclerosis |
Goyne C et al. |
Neurology |
Aging, Epigenetics |
|
|
2024 |
Patient and family views on research priorities and design of clinical trials and research studies in pediatric multiple sclerosis |
O'Donnell E et al. |
Mult Scler. |
Research Participation, Patient Perspectives |
|
|
2024 |
Early Adversity and Socioeconomic Factors in Pediatric Multiple Sclerosis A Case-Control Study |
Jensen S et al. |
Neurol Neuroimmunol Neuroinflamm |
Social Determinants, Risk Factors |
|
|
2024 |
Association of nutritional intake with clinical and imaging activity in pediatric multiple sclerosis |
Mohan S et al. |
Mult Scler. |
Nutrition, Imaging, Outcomes |
|
|
2024 |
Increased intraindividual variability (IIV) in reaction time is the earliest indicator of cognitive change in MS: A two-year observational study |
Pilloni G et al. |
International Journal of Clinical and Health Psychology |
Cognition, Outcomes |
|
|
2024 |
Clinical and magnetic resonance imaging outcomes in pediatric-onset MS patients on fingolimod and ocrelizumab |
Nasr Z et al. |
Mult Scler Relat Disord. |
Treatment, Imaging, Outcomes |
|
|
2024 |
Gene–environment interactions: Epstein–Barr virus infection and risk of pediatric-onset multiple sclerosis |
Ziaei A et al. |
Mult Scler. |
Environmental Exposure, Infection, Risk Factors |
|
|
2024 |
Gene-environment interactions and risk of pediatric-onset multiple sclerosis associated with time spent outdoors |
Nasr Z et al. |
Mult Scler Relat Disord. |
Environmental Exposure, Risk Factors |
|
|
2024 |
Assessing Needs and Perceptions of Research Participation in Pediatric-Onset Multiple Sclerosis: A Multistakeholder Survey |
Gambrah-Lyles C et al. |
Pediatr Neurol. |
Research Participation, Patient Perspectives |
|
|
2023 |
Demographic Features and Clinical Course of Patients With Pediatric-Onset Multiple Sclerosis on Newer Disease-Modifying Treatments |
Shukla, N et al. |
Pediatr Neurol. |
Treatment, Outcomes |
|
|
2023 |
Gene-environment interactions increase the risk of paediatric-onset multiple sclerosis associated with household chemical exposures |
Nasr Z et al. |
J Neurol Neurosurg Psychiatry |
Environmental Exposure, Risk Factors |
|
|
2023 |
Characteristics of pediatric patients with multiple sclerosis and related disorders infected with SARS-CoV-2 |
Schreiner T et al. |
Mult Scler. |
Infection, COVID-19 |
|
|
2023 |
Rare and low-frequency coding genetic variants contribute to pediatric-onset multiple sclerosis |
Horton MK et al. |
Mult Scler. |
Genetics |
|
|
2023 |
Silent findings: Examination of asymptomatic demyelination in a pediatric US cohort |
Bhise V et al. |
Mult Scler Relat Disord. |
Demyelinating Disease, Imaging |
|
|
2023 |
Therapeutic Response in Pediatric Neuromyelitis Optica Spectrum Disorder |
Umeton, R et al. |
Neurology |
Treatment, NMOSD |
|
|
2023 |
MOG and AQP4 Antibodies among Children with Multiple Sclerosis and Controls |
Gaudioso CM et al. |
Ann Neurol. |
MOG, AQP4, Pediatric MS |
|
|
2023 |
Therapeutic Response in Pediatric Neuromyelitis Optica Spectrum Disorder |
Pizzolato Umeton R et al. |
Neurology |
Treatment, NMOSD |
|
|
2023 |
A new look at cognitive functioning in pediatric MS |
Krupp LB et al. |
Mult Scler. |
Cognition |
|
|
2023 |
Characteristics of pediatric patients with multiple sclerosis and related disorders infected with SARS-CoV-2 |
Schreiner T et al. |
Mult Scler. |
COVID-19, Infection |
|
|
2023 |
Association Between Time Spent Outdoors and Risk of Multiple Sclerosis |
Sebastian P et al. |
Neurology |
Environmental Exposure |
|
|
2023 |
Gene-environment interactions increase the risk of paediatric-onset multiple sclerosis associated with household chemical exposures |
Nasr Z et al. |
J Neurol Neurosurg Psychiatry |
Environmental Exposure, Genetics |
|
|
2023 |
Silent findings: Examination of asymptomatic demyelination in a pediatric US cohort |
Bhise V et al. |
Mult Scler Relat Disord. |
Demyelinating Disease |
|
|
2023 |
Demographic Features and Clinical Course of Patients With Pediatric-Onset Multiple Sclerosis on Newer Disease-Modifying Treatments |
Malani Shukla N et al. |
Pediatr Neurol. |
Treatment, Outcomes |
|
|
2023 |
Rare and low-frequency coding genetic variants contribute to pediatric-onset multiple sclerosis |
Horton MK et al. |
Mult Scler. |
Genetics |
|
|
2023 |
Assessing Needs and Perceptions of Research Participation in Pediatric-Onset Multiple Sclerosis: A Multistakeholder Survey |
Gambrah-Lyles C et al. |
Pediatr Neurol. |
Research Participation |
|
|
2023 |
Short-chain fatty acid producers in the gut are associated with pediatric multiple sclerosis onset |
Schoeps VA et al. |
Ann Clin Transl Neurol. |
Microbiome, Pediatrics |
|
|
2023 |
Gene-environment interactions and risk of pediatric-onset multiple sclerosis associated with time spent outdoors |
Nasr Z et al. |
Mult Scler Relat Disord. |
Environmental Exposure, Genetics |
|
|
2022 |
Gene-environment interactions increase the risk of pediatric-onset multiple sclerosis associated with ozone pollution |
Ziaei A et al. |
Mult Scler. |
Environmental Exposure |
|
|
2022 |
Menarche and Relapses in Girls with Pediatric Multiple Sclerosis |
Krysko K et al. |
Neurology |
Hormones, Relapse |
|
|
2021 |
Family Perspectives on Clinical Research for Pediatric Multiple Sclerosis: Enhancing Equity |
Mandel LA et al. |
J Patient Exp. |
Research Participation |
|
|
2021 |
Increased Prevalence of Familial Autoimmune Disease in Children with Opsoclonus-Myoclonus Syndrome |
Santoro JD et al. |
Neurol Neuroimmunol Neuroinflamm |
Autoimmune Disease |
|
|
2021 |
Familial History of Autoimmune Disorders Among Pediatric Multiple Sclerosis Patients |
Greenberg BM et al. |
Neurol Neuroimmunol Neuroinflamm |
Autoimmune Disease |
|
|
2021 |
PedsQL Multiple Sclerosis Module Domain and Item Development: Qualitative Methods |
Gaudioso C et al. |
J Child Neurol. |
Quality of Life, Methods |
|
|
2021 |
Gut microbiome is associated with multiple sclerosis activity in children |
Horton MK et al. |
Ann Clin Transl Neurol. |
Microbiome, Disease Activity |
|
|
2020 |
Cognitive processing speed in pediatric-onset multiple sclerosis: Baseline characteristics of impairment and prediction of decline |
Wallach Al et al. |
Multiple Sclerosis Journal |
Cognition, Outcomes |
|
|
2020 |
Real-World Effectiveness of Initial Disease-Modifying Therapies in Pediatric Multiple Sclerosis |
Krysko KM et al. |
Ann Neurol. |
Treatment, Outcomes |
|
|
2020 |
Pediatric Multiple Sclerosis Severity score in a Large U.S. Cohort |
Santoro JD et al. |
Neurology |
Outcomes, Severity Score |
|
|
2020 |
Improved relapse recovery in pediatric compared to adult multiple sclerosis |
Chitnis T et al. |
Brain |
Relapse, Outcomes |
|
|
2019 |
Vitamin D genes influence MS relapses in children |
Graves J et al. |
Multiple Sclerosis |
Vitamin D, Genetics |
|
|
2019 |
miRNA contributions to pediatric-onset multiple sclerosis inferred from GWAS |
Rhead B et al. |
Ann Clin Transl Neurol. |
Genetics |
|
|
2019 |
Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry |
Chi C et al. |
PLoS Genet |
Genetics |
|
|
2018 |
Acquisition of Early Developmental Milestones and Need for Special Education Services in Pediatric Multiple Sclerosis |
Aaen G et al. |
J Child Neurol. |
Development, Education |
|
|
2018 |
Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US |
Krysko K et al. |
Neurology |
Treatment |
|
|
2018 |
Several Household Chemical Exposures are associated with Pediatric-Onset Multiple Sclerosis |
Mar S et al. |
Ann Clin Transl Neurol. |
Environmental Exposure |
|
|
2018 |
Urban air quality and associations with pediatric multiple sclerosis |
Lavery A et al. |
Ann Clin Transl Neurol. |
Environmental Exposure |
|
|
2018 |
Heterogeneity in association of remote herpesvirus infections and pediatric MS |
Nourbakhsh B et al. |
Ann Clin Transl Neurol. |
Infection |
|
|
2018 |
Dietary factors and pediatric multiple sclerosis: a case-control study |
Pakpoor J et al. |
Multiple Sclerosis |
Nutrition |
|
|
2018 |
Early infectious exposures are not associated with increased risk of pediatric-onset multiple sclerosis |
Suleiman L et al. |
Mult Scler Relat Disord. |
Infection |
|
|
2018 |
Contribution of dietary intake to relapse rate in early paediatric multiple sclerosis |
Azary S et al. |
J Neurol Neurosurg Psychiatry |
Nutrition, Relapse |
|
|
2017 |
Examining the contributions of environmental quality to pediatric multiple sclerosis |
Lavery A et al. |
Mult Scler Relat Disord. |
Environmental Exposure |
|
|
2017 |
Pediatric Demyelinating Diseases of the Central Nervous System and Their Mimics |
Waubant E, Lotze T |
Springer International Publishing |
Reference, Demyelinating Disorders |
|
|
2017 |
Genetic risk factors for pediatric-onset multiple sclerosis |
Gianfrancesco M et al. |
Multiple Sclerosis |
Genetics |
|
|
2017 |
Maternal and Perinatal Exposures Are Associated With Risk for Pediatric-Onset Multiple Sclerosis |
Graves J et al. |
Pediatrics |
Environmental Exposure |
|
|
2017 |
Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS |
Gianfrancesco M et al. |
Neurology |
Vitamin D, BMI, Genetics |
|
|
2017 |
Evaluating the association of allergies with multiple sclerosis susceptibility risk and disease activity in a pediatric population |
Bourne T et al. |
J Neurol Sci. |
Allergies |
|
|
2016 |
Distinct effects of obesity and puberty on risk and age at onset of pediatric MS |
Chitnis T et al. |
Ann Clin Transl Neurol. |
BMI, Puberty, Risk |
|
|
2016 |
Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls |
Tremlett H et al. |
BMC Neurol. |
Microbiome, Immunology |
|
|
2016 |
Characteristics of Children and Adolescents With Multiple Sclerosis |
Belman A et al. |
Pediatrics |
Clinical Characteristics |
|
|
2016 |
Dietary salt intake and time to relapse in paediatric multiple sclerosis |
Nourbakhsh B et al. |
J Neurol Neurosurg Psychiatry |
Nutrition, Relapse |
|
|
2016 |
Gut microbiota in early pediatric multiple sclerosis: a case-control study |
Tremlett H et al. |
Eur J Neurol. |
Microbiome |
|
|
2016 |
A case-control study of dietary salt intake in pediatric-onset multiple sclerosis |
McDonald J et al. |
Mult Scler Relat Disord. |
Nutrition |
|
|
2016 |
Gut microbiota composition and relapse risk in pediatric MS: A pilot study |
Tremlett H et al. |
J Neurol Sci. |
Microbiome, Relapse |
|
|
2016 |
Genetic predictors of relapse rate in pediatric MS |
Graves J et al. |
Multiple Sclerosis |
Genetics, Relapse |
|
|
2016 |
Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report |
Chitnis T et al. |
Neurology |
NMOSD |
|
|
2014 |
Protective environmental factors for neuromyelitis optica. For the US Network of Pediatric Multiple Sclerosis Centers |
Graves J et al. |
Neurology |
NMOSD, Environmental Exposure |
|
|
2014 |
The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps |
Casper TC et al. |
J Child Neurol. |
Network History |
|
|
2014 |
Longitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the US Pediatric Multiple Sclerosis Network |
Charvet LE et al. |
Mult Scler. |
Cognition, Longitudinal |
|
|
2014 |
Social cognition in pediatric-onset multiple sclerosis (MS) |
Charvet L et al. |
Mult Scler. |
Cognition |
|
|
2013 |
Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study |
Chitnis T et al. |
BMC Neurol. |
Imaging |
|
|
2013 |
Cognitive impairment occurs early in pediatric multiple sclerosis: Results from a US network |
Julian L et al. |
Journal of Child Neurology |
Cognition |
|
|
2011 |
Management of pediatric central nervous system demyelinating disorders: consensus of United States neurologists |
Waldman AT et al. |
J Child Neurol. |
Clinical Care, Consensus |
|
|
2011 |
Multiple sclerosis therapies in pediatric patients with refractory multiple sclerosis |
Yeh EA et al. |
Archives of Neurology |
Treatment |
|
|
2011 |
Common viruses associated with lower pediatric multiple sclerosis risk |
Waubant E et al. |
Neurology |
Infection, Risk |
|
|
2011 |
Pediatric multiple sclerosis |
Chitnis T et al. |
Neurol Clin. |
Review |
|
|
2010 |
Treatment of multiple sclerosis in children and adolescents |
Kuntz NL et al. |
Expert Opin Pharmacother. |
Treatment |
|
|
2010 |
Younger children with MS have a distinct CSF inflammatory profile at disease onset |
Chabas D et al. |
Neurology |
CSF, Inflammation |
|
|
2009 |
Pediatric multiple sclerosis |
Yeh EA et al. |
Nat Rev Neurol. |
Review |
